Patients requiring total hysterectomy under laparoscopy
Conditions
Interventions
Q1:Q1 group transition analgesia used 5mg oxycodone hydrochloride injection
Q2:Q2 group transition analgesia using 3mg oxycodone injection + 0.4mg butorphanol tartrate injection
Q3:Q3 group transition analgesia using 1mg oxycodone injection + 0.8mg butorphanol tartrate injection
Q4:Q4 group transition analgesia using 1mg/butorphanol tartrate injection
Sponsors
Benxi Central Hospital
Eligibility
Sex/Gender
Female
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Female, age 35-65 years; 2. BMI 18-28kg/m²; 3. Patients who plan to undergo laparoscopic surgery under general anesthesia with ASA grade I or II; 4. Patients who plan to receive postoperative analgesia; 5. Sign the anesthesia informed consent form; 6. Good mental state and able to cooperate with postoperative investigation;
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiovascular or respiratory diseases; 2. Those with severe hypertension, diabetes, or atherosclerosis; 3. Individuals with pre-existing chronic pain prior to surgery; 4. Patients with a history of drug abuse or prolonged opioid use; 5. Patients with severe mental disorders or those requiring long-term antipsychotic medication; 6. Patients experiencing intraoperative blood loss = 400ml
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| degree of comfort ;sedation ;Dosage of analgesics;Wake up time;untoward effect ; | — |
Countries
China
Contacts
Public ContactWang Shu
Benxi Central Hospital
Outcome results
None listed